Traws Pharma's total assets for Q4 2023 were $18.17M, a decrease of -32.79% from the previous quarter. TRAW total liabilities were $12.16M for the fiscal quarter, a -2.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.